Temat: "glucagon" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: The Road towards Triple Agonists: Glucagon-Like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Glucagon Receptor - An Update.
Autorzy:: Jakubowska A; Borthwick Diabetes Research Centre, Lister Hospital, Stevenage, UK.
Roux CWL; Diabetes Complications Research Centre, University College Dublin, Dublin, Ireland.
Viljoen A; Borthwick Diabetes Research Centre, Lister Hospital, Stevenage, UK.; Pokaż więcej
Źródło:: Endocrinology and metabolism (Seoul, Korea) [Endocrinol Metab (Seoul)] 2024 Feb; Vol. 39 (1), pp. 12-22. Date of Electronic Publication: 2024 Feb 14.
Typ publikacji:: Review; Journal Article
MeSH Terms:: Glucagon-Like Peptide 1*/pharmacology
Glucagon-Like Peptide 1*/therapeutic use
Diabetes Mellitus, Type 2*/drug therapy
Receptors, Gastrointestinal Hormone*
Humans ; Receptors, Glucagon/therapeutic use ; Gastric Inhibitory Polypeptide/pharmacology ; Gastric Inhibitory Polypeptide/physiology ; Gastric Inhibitory Polypeptide/therapeutic use ; Obesity/drug therapy ; Weight Loss ; Receptors, G-Protein-Coupled ; Glucose ; Randomized Controlled Trials as Topic ; Clinical Trials, Phase II as Topic

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors on Intima-Media Thickness: Systematic Review and Meta-Analysis.
Autorzy:: Akbari A; Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.; Research Center for Advanced Technologies in Cardiovascular Medicine, Cardiovascular Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Hadizadeh S; Research Center for Advanced Technologies in Cardiovascular Medicine, Cardiovascular Research Institute, Tehran University of Medical Sciences, Tehran, Iran.; Women Reproductive Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Heidary L; Laboratory of Medical Genetics, ART and Stem Cell Research Centre (ACECR), Tabriz, Iran.; Nahal Infertility Center, Tabriz, Iran.; Pokaż więcej
Źródło:: Journal of diabetes research [J Diabetes Res] 2024 Mar 18; Vol. 2024, pp. 3212795. Date of Electronic Publication: 2024 Mar 18 (Print Publication: 2024).
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:: Carotid Intima-Media Thickness*
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Glucagon-Like Peptide-1 Receptor Agonists*/therapeutic use
Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use
Humans ; Glucagon-Like Peptide 1/therapeutic use ; Glucagon-Like Peptide-1 Receptor/agonists ; Hypoglycemic Agents/pharmacology ; Hypoglycemic Agents/therapeutic use ; Cardiovascular Diseases/drug therapy ; Cardiovascular Diseases/prevention & control

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Evidence that tirzepatide protects against diabetes-related cardiac damages.
Autorzy:: Taktaz F; Department of Advanced Medical and Surgical Sciences, University of Campania ''Luigi Vanvitelli'', P.zza L. Miraglia, 2, 80138, Naples, Italy.
Scisciola L; Department of Advanced Medical and Surgical Sciences, University of Campania ''Luigi Vanvitelli'', P.zza L. Miraglia, 2, 80138, Naples, Italy. .
Fontanella RA; Department of Advanced Medical and Surgical Sciences, University of Campania ''Luigi Vanvitelli'', P.zza L. Miraglia, 2, 80138, Naples, Italy.
Pesapane A; Department of Advanced Medical and Surgical Sciences, University of Campania ''Luigi Vanvitelli'', P.zza L. Miraglia, 2, 80138, Naples, Italy.
Ghosh P; Department of Advanced Medical and Surgical Sciences, University of Campania ''Luigi Vanvitelli'', P.zza L. Miraglia, 2, 80138, Naples, Italy.
Franzese M; Department of Advanced Medical and Surgical Sciences, University of Campania ''Luigi Vanvitelli'', P.zza L. Miraglia, 2, 80138, Naples, Italy.
Tortorella G; Department of Advanced Medical and Surgical Sciences, University of Campania ''Luigi Vanvitelli'', P.zza L. Miraglia, 2, 80138, Naples, Italy.
Puocci A; Department of Advanced Medical and Surgical Sciences, University of Campania ''Luigi Vanvitelli'', P.zza L. Miraglia, 2, 80138, Naples, Italy.
Sommella E; Department of Pharmacy, University of Salerno, Fisciano, SA, Italy.
Signoriello G; Department of Mental Health and Public Medicine, Section of Statistic, University of Campania, Naples, Italy.
Olivieri F; Department of Clinical and Molecular Sciences, DISCLIMO, Università Politecnica delle Marche, Ancona, Italy.; Center of Clinical Pathology and Innovative Therapy, IRCCS INRCA, Ancona, Italy.
Barbieri M; Department of Advanced Medical and Surgical Sciences, University of Campania ''Luigi Vanvitelli'', P.zza L. Miraglia, 2, 80138, Naples, Italy.
Paolisso G; Department of Advanced Medical and Surgical Sciences, University of Campania ''Luigi Vanvitelli'', P.zza L. Miraglia, 2, 80138, Naples, Italy.; UniCamillus, International Medical University, Rome, Italy.; Pokaż więcej
Źródło:: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Mar 30; Vol. 23 (1), pp. 112. Date of Electronic Publication: 2024 Mar 30.
Typ publikacji:: Meta-Analysis; Journal Article
MeSH Terms:: Heart Failure*/prevention & control
Diabetes Mellitus*/diagnosis
Diabetes Mellitus*/drug therapy
Diabetes Mellitus, Type 2*
Glucagon-Like Peptide-2 Receptor*
Gastric Inhibitory Polypeptide*
Humans ; Hypertrophy ; Hypoglycemic Agents/pharmacology ; Myocytes, Cardiac ; Fibrosis ; Glucose ; Glucagon-Like Peptide-1 Receptor

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Repressing miR-23a promotes the transdifferentiation of pancreatic α cells to β cells via negatively regulating the expression of SDF-1α.
Autorzy:: Lang H; Department of General Medicine, Chengdu Second People's Hospital, Chengdu, Sichuan Province, China.
Lin N; Department of Clinical Nutrition, the General Hospital of Western Theater Command, Chengdu, Sichuan Province, China.
Chen X; Department of General Medicine, Chengdu Second People's Hospital, Chengdu, Sichuan Province, China.; College of Medicine of Southwest Jiaotong University, Chengdu, Sichuan Province, China.
Xiang J; Department of General Medicine, Chengdu Second People's Hospital, Chengdu, Sichuan Province, China.; College of Medicine of Southwest Jiaotong University, Chengdu, Sichuan Province, China.
Zhang X; Department of General Medicine, Chengdu Second People's Hospital, Chengdu, Sichuan Province, China.
Kang C; Department of Clinical Nutrition, the General Hospital of Western Theater Command, Chengdu, Sichuan Province, China.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Mar 22; Vol. 19 (3), pp. e0299821. Date of Electronic Publication: 2024 Mar 22 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Glucagon-Secreting Cells*/metabolism
Insulin-Secreting Cells*/metabolism
MicroRNAs*/genetics
MicroRNAs*/metabolism
Animals ; Mice ; Cell Transdifferentiation/genetics ; Chemokine CXCL12/genetics ; Chemokine CXCL12/metabolism ; Glucagon

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Evidence for dopamine production and distribution of dopamine D2 receptors in the equine gastrointestinal mucosa and pancreas.
Autorzy:: Galinelli NC; Melbourne Veterinary School, Faculty of Science, The University of Melbourne, Parkville, Victoria, Australia.
Bamford NJ; Melbourne Veterinary School, Faculty of Science, The University of Melbourne, Parkville, Victoria, Australia.
de Laat MA; School of Biology and Environmental Science, Faculty of Science, Queensland University of Technology, Brisbane, Queensland, Australia.
Sillence MN; School of Biology and Environmental Science, Faculty of Science, Queensland University of Technology, Brisbane, Queensland, Australia.
Harris PA; Equine Studies Group, Waltham Petcare Science Institute, Melton Mowbray, United Kingdom.
Bailey SR; Melbourne Veterinary School, Faculty of Science, The University of Melbourne, Parkville, Victoria, Australia.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Feb 27; Vol. 19 (2), pp. e0298660. Date of Electronic Publication: 2024 Feb 27 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Dopamine*
Glucagon-Secreting Cells*
Animals ; Horses ; Receptors, Dopamine D2 ; Glucagon ; Pancreas ; Gastrointestinal Tract/chemistry ; Insulin ; Mucous Membrane ; Receptors, Dopamine D1

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Tirzepatide prevents neurodegeneration through multiple molecular pathways.
Autorzy:: Fontanella RA; Department of Advanced Medical and Surgical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Ghosh P; Department of Advanced Medical and Surgical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Pesapane A; Department of Advanced Medical and Surgical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Taktaz F; Department of Advanced Medical and Surgical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Puocci A; Department of Advanced Medical and Surgical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Franzese M; Department of Advanced Medical and Surgical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Feliciano MF; Department of Advanced Medical and Surgical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Tortorella G; Department of Advanced Medical and Surgical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Scisciola L; Department of Advanced Medical and Surgical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy. .
Sommella E; Department of Pharmacy, University of Salerno, Fisciano, SA, Italy.
Ambrosino C; Biogem Institute of Molecular Biology and Genetics, Ariano Irpino, Italy.; Department of Science and Technology, University of Sannio, Benevento, Italy.
Paolisso G; Department of Advanced Medical and Surgical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy.; UniCamillus, International Medical University, Rome, Italy.
Barbieri M; Department of Advanced Medical and Surgical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy.; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2024 Jan 29; Vol. 22 (1), pp. 114. Date of Electronic Publication: 2024 Jan 29.
Typ publikacji:: Journal Article
MeSH Terms:: Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/metabolism
Insulin Resistance*
MicroRNAs*
Glucagon-Like Peptide-2 Receptor*
Gastric Inhibitory Polypeptide*
Humans ; Insulin/metabolism ; Brain-Derived Neurotrophic Factor ; Blood Glucose/metabolism ; Glucagon-Like Peptide-1 Receptor/agonists ; Hypoglycemic Agents/pharmacology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Glucagon and Its Receptors in the Mammalian Heart.
Autorzy:: Neumann J; Institute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, Magdeburger Straße 4, D-06097 Halle (Saale), Germany.
Hofmann B; Department of Cardiac Surgery, Mid-German Heart Center, University Hospital Halle, Ernst Grube Straße 40, D-06097 Halle (Saale), Germany.
Dhein S; Rudolf-Boehm Institut für Pharmakologie und Toxikologie, Universität Leipzig, Härtelstraße 16-18, D-04107 Leipzig, Germany.
Gergs U; Institute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, Magdeburger Straße 4, D-06097 Halle (Saale), Germany.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Aug 15; Vol. 24 (16). Date of Electronic Publication: 2023 Aug 15.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Glucagon*
Receptors, Glucagon*
Humans ; Animals ; Mice ; Heart ; Heart Conduction System ; Antibodies ; Glucagon-Like Peptide-1 Receptor ; Mammals

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Alpha cell receptor for advanced glycation end products associate with glucagon expression in type 1 diabetes.
Autorzy:: Leung SS; Glycation and Diabetes Complications, Mater Research Institute, Translational Research Institute (TRI), The University of Queensland (MRI-UQ), 37 Kent Street, Woolloongabba, Brisbane, QLD, 4102, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Australia.; School of Medicine and Dentistry, Griffith University, Brisbane, Australia.; Wesley Research Institute, The Wesley Hospital, Brisbane, Australia.
Lenchik N; Division of Endocrinology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.
Mathews C; Division of Endocrinology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.
Pugliese A; Division of Endocrinology, Department of Microbiology and Immunology, Department of Medicine, Diabetes Research Institute, Miller School of Medicine, University of Miami, Miami, FL, USA.
McCarthy DA; Glycation and Diabetes Complications, Mater Research Institute, Translational Research Institute (TRI), The University of Queensland (MRI-UQ), 37 Kent Street, Woolloongabba, Brisbane, QLD, 4102, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Australia.
Le Bagge S; Glycation and Diabetes Complications, Mater Research Institute, Translational Research Institute (TRI), The University of Queensland (MRI-UQ), 37 Kent Street, Woolloongabba, Brisbane, QLD, 4102, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Australia.
Ewing A; Faculty of Medicine, The University of Queensland, Brisbane, Australia.; Translational Bioinformatics Group, MRI-UQ, TRI, Brisbane, Australia.
Harris M; Faculty of Medicine, The University of Queensland, Brisbane, Australia.; Queensland Diabetes Centre, Mater Health Services, Brisbane, Australia.
Radford KJ; Faculty of Medicine, The University of Queensland, Brisbane, Australia.; Cancer Immunotherapies Group, MRI-UQ, TRI, Brisbane, Australia.
Borg DJ; Glycation and Diabetes Complications, Mater Research Institute, Translational Research Institute (TRI), The University of Queensland (MRI-UQ), 37 Kent Street, Woolloongabba, Brisbane, QLD, 4102, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Australia.
Gerling I; Division of Endocrinology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.
Forbes JM; Glycation and Diabetes Complications, Mater Research Institute, Translational Research Institute (TRI), The University of Queensland (MRI-UQ), 37 Kent Street, Woolloongabba, Brisbane, QLD, 4102, Australia. .; Faculty of Medicine, The University of Queensland, Brisbane, Australia. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Aug 09; Vol. 13 (1), pp. 12948. Date of Electronic Publication: 2023 Aug 09.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Diabetes Mellitus, Type 1*/genetics
Glucagon-Secreting Cells*/metabolism
Hypoglycemia*
Receptor for Advanced Glycation End Products*/metabolism
Adolescent ; Humans ; Glucagon ; Glycation End Products, Advanced/metabolism ; Ligands

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Newly discovered knowledge pertaining to glucagon and its clinical applications.
Autorzy:: Kawamori D; Medical Education Center, Faculty of Medicine, Osaka University, Osaka, Japan.; Postgraduate Medical Training Center, Osaka University Hospital, Osaka University, Osaka, Japan.; Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.
Sasaki S; Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.; Pokaż więcej
Źródło:: Journal of diabetes investigation [J Diabetes Investig] 2023 Jul; Vol. 14 (7), pp. 829-837. Date of Electronic Publication: 2023 Apr 13.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Diabetes Mellitus*/metabolism
Glucagon-Secreting Cells*/metabolism
Humans ; Glucagon ; Insulin/metabolism ; Glucose/metabolism ; Blood Glucose/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Brown Adipose Tissue: A New Potential Target for Glucagon-like Peptide 1 Receptor Agonists in the Treatment of Obesity.
Autorzy:: Hropot T; Department of Pediatric Endocrinology, Diabetes and Metabolic Diseases, University Children's Hospital, 1000 Ljubljana, Slovenia.
Herman R; Department for Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.; Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
Janez A; Department for Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.; Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
Lezaic L; Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.; Department for Nuclear Medicine, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
Jensterle M; Department for Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.; Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 May 11; Vol. 24 (10). Date of Electronic Publication: 2023 May 11.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Adipose Tissue, Brown*/metabolism
Cardiovascular Diseases*/metabolism
Obesity*/metabolism
Glucagon-Like Peptide-1 Receptor*/agonists
Humans ; Adipose Tissue, White/metabolism ; Energy Metabolism ; Glucagon-Like Peptide 1/metabolism ; Thermogenesis ; Weight Loss ; Animals

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Glucagon-like peptide-1 receptor agonists to expand the healthy lifespan: Current and future potentials.
Autorzy:: Kreiner FF; Global Medical Affairs, Novo Nordisk A/S, Søborg, Denmark.
von Scholten BJ; Global Medical Affairs, Novo Nordisk A/S, Søborg, Denmark.
Kurtzhals P; Global Medical Affairs, Novo Nordisk A/S, Søborg, Denmark.
Gough SCL; Global Medical Affairs, Novo Nordisk A/S, Søborg, Denmark.; Pokaż więcej
Źródło:: Aging cell [Aging Cell] 2023 May; Vol. 22 (5), pp. e13818. Date of Electronic Publication: 2023 Mar 20.
Typ publikacji:: Journal Article
MeSH Terms:: Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/metabolism
Glucagon-Like Peptide-1 Receptor*/agonists
Hypoglycemic Agents*/therapeutic use
Humans ; Glucagon-Like Peptide 1/metabolism ; Longevity

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Glucagon-like peptide-1 facilitates cerebellar parallel fiber glutamate release through PKA signaling in mice in vitro.
Autorzy:: Wang XY; Department of Neurology, Affiliated Hospital of Yanbian University, Yanji, 133000, Jilin, China.
Liu Y; Department of Physiology, College of Basic Medicine, Jilin Medical University, Jilin, 132013, Jilin, China.
Cao LX; Department of Physiology and Pathophysiology, College of Medicine, Yanbian University, Yanji, 133000, Jilin, China.
Li YZ; Department of Cardiology, Affiliated Hospital of Yanbian University, Yanji, 133000, Jilin, China.
Wan P; Department of Physiology, College of Basic Medicine, Jilin Medical University, Jilin, 132013, Jilin, China. Wpeng_.
Qiu DL; Department of Physiology, College of Basic Medicine, Jilin Medical University, Jilin, 132013, Jilin, China. dlqiu_.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 May 16; Vol. 13 (1), pp. 7948. Date of Electronic Publication: 2023 May 16.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Glutamic Acid*/pharmacology
Glucagon-Like Peptide 1*/pharmacology
Mice ; Animals ; Glucagon-Like Peptide-1 Receptor ; Cerebellum/physiology ; Purkinje Cells/physiology ; Synaptic Transmission/physiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Salivary Hormones Leptin, Ghrelin, Glucagon, and Glucagon-Like Peptide 1 and Their Relation to Sweet Taste Perception in Diabetic Patients.
Autorzy:: Al-Ghurayr NK; Biochemistry Department, Faculty of Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Al-Mowalad AM; Biochemistry Department, Faculty of Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Omar UM; Biochemistry Department, Faculty of Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.; Princess Dr. Najla Bint Saud Al-Saud Center for Excellence Research in Biotechnology, King Abdulaziz University, Jeddah, Saudi Arabia.
Ashi HM; Department of Dental Public Health, Faculty of Dentistry, King Abdulaziz University, Jeddah, Saudi Arabia.
Al-Shehri SS; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.
AlShaikh AA; Department of Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
AlHarbi SM; Albawadi 1 Primary Health Care Center, King Fahad Hospital, Ministry of Health, Jeddah, Saudi Arabia.
Alsufiani HM; Biochemistry Department, Faculty of Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.; Experimental Biochemistry Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.; Pokaż więcej
Źródło:: Journal of diabetes research [J Diabetes Res] 2023 May 15; Vol. 2023, pp. 7559078. Date of Electronic Publication: 2023 May 15 (Print Publication: 2023).
Typ publikacji:: Journal Article
MeSH Terms:: Glucagon*
Diabetes Mellitus*
Humans ; Glucagon-Like Peptide 1 ; Taste ; Ghrelin ; Taste Perception ; Leptin ; Transcription Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Secretion of glucagon, GLP-1 and GIP may be affected by circadian rhythm in healthy males.
Autorzy:: Zilstorff DB; Department of Clinical Biochemistry, Copenhagen University Hospital - Bispebjerg Hospital, Copenhagen, Denmark.
Richter MM; Department of Clinical Biochemistry, Copenhagen University Hospital - Bispebjerg Hospital, Copenhagen, Denmark.; NNF Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Hannibal J; Department of Clinical Biochemistry, Copenhagen University Hospital - Bispebjerg Hospital, Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Jørgensen HL; Department of Clinical Biochemistry, Copenhagen University Hospital - Hvidovre, Hvidovre, Denmark.
Sennels HP; Department of Clinical Biochemistry, Copenhagen University Hospital - Bispebjerg Hospital, Copenhagen, Denmark.
Wewer Albrechtsen NJ; Department of Clinical Biochemistry, Copenhagen University Hospital - Bispebjerg Hospital, Copenhagen, Denmark. .; NNF Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. .; Pokaż więcej
Źródło:: BMC endocrine disorders [BMC Endocr Disord] 2024 Mar 14; Vol. 24 (1), pp. 38. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:: Journal Article
MeSH Terms:: Glucagon*/metabolism
Glucagon-Like Peptide 1*
Male ; Humans ; Insulin ; C-Peptide ; Gastric Inhibitory Polypeptide ; Blood Glucose/metabolism ; Glucose/pharmacology ; Circadian Rhythm

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Time-dependent effect of GLP-1 receptor agonists on cardiovascular benefits: a real-world study.
Autorzy:: Piccini S; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072, Pieve Emanuele, Milan, Italy.; Endocrinology, Diabetology and Andrology Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089, Rozzano, Milan, Italy.
Favacchio G; Endocrinology, Diabetology and Andrology Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089, Rozzano, Milan, Italy.
Panico C; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072, Pieve Emanuele, Milan, Italy.; Department of Cardiology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
Morenghi E; Biostatistic Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089, Rozzano, Milan, Italy.
Folli F; Endocrinology and Metabolism, Department of Health Science, Università Degli Studi di Milano, Milan, Italy.
Mazziotti G; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072, Pieve Emanuele, Milan, Italy.; Endocrinology, Diabetology and Andrology Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089, Rozzano, Milan, Italy.
Lania AG; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072, Pieve Emanuele, Milan, Italy.; Endocrinology, Diabetology and Andrology Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089, Rozzano, Milan, Italy.
Mirani M; Endocrinology, Diabetology and Andrology Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089, Rozzano, Milan, Italy. .; Pokaż więcej
Źródło:: Cardiovascular diabetology [Cardiovasc Diabetol] 2023 Mar 25; Vol. 22 (1), pp. 69. Date of Electronic Publication: 2023 Mar 25.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Cardiovascular Diseases*/diagnosis
Cardiovascular Diseases*/epidemiology
Cardiovascular Diseases*/prevention & control
Diabetes Mellitus, Type 2*/diagnosis
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/epidemiology
Glucagon-Like Peptide-1 Receptor*/agonists
Humans ; Glucagon-Like Peptide 1 ; Glycated Hemoglobin ; Hypoglycemic Agents ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: The cardiovascular and renal effects of glucagon-like peptide 1 receptor agonists in patients with advanced diabetic kidney disease.
Autorzy:: Lin Y; Department of Emergency Medicine, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan.; Chang Gung University, Taoyuan, Taiwan.
Wang TH; Department of Emergency Medicine, Medical Research Institute, Tazuke Kofukai, Kitano Hospital, Osaka, Japan.; Department of Primary Care and Emergency Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Tsai ML; Division of Cardiology, Department of Internal Medicine, New Taipei Municipal TuCheng Hospital, New Taipei City, Taiwan.; College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Wu VC; Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan.
Tseng CJ; Department of Internal Medicine, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan.
Lin MS; Division of Cardiology, Department of Internal Medicine, Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan.
Li YR; Chang Gung University, Taoyuan, Taiwan.; Division of Endocrinology and Metabolism, Department of Internal Medicine , Chang Gung Memorial Hospital, Linkou Medical Center , Taoyuan, Taiwan.
Chang CH; Division of Nephrology, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan.
Chou TS; Division of Gastroenterology, Department of Internal Medicine, Keelung Chang Gung Memorial Hospital , Keelung, Taiwan.
Tsai TH; Division of Cardiology, Department of Internal Medicine, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi, Taiwan.
Yang NI; Chang Gung University, Taoyuan, Taiwan.; Division of Cardiology, Department of Internal Medicine, Keelung Chang Gung Memorial Hospital, No. 222, Maijin Rd Anle Dist., Keelung, 204, Taiwan.
Hung MJ; Division of Cardiology, Department of Internal Medicine, Keelung Chang Gung Memorial Hospital, No. 222, Maijin Rd Anle Dist., Keelung, 204, Taiwan.
Chen TH; Division of Cardiology, Department of Internal Medicine, Keelung Chang Gung Memorial Hospital, No. 222, Maijin Rd Anle Dist., Keelung, 204, Taiwan. .; School of Traditional Chinese Medicine, Chang Gung University, Taoyuan, Taiwan. .; Pokaż więcej
Źródło:: Cardiovascular diabetology [Cardiovasc Diabetol] 2023 Mar 17; Vol. 22 (1), pp. 60. Date of Electronic Publication: 2023 Mar 17.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Cardiovascular Diseases*/diagnosis
Cardiovascular Diseases*/epidemiology
Cardiovascular Diseases*/prevention & control
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/diagnosis
Diabetes Mellitus, Type 2*/drug therapy
Diabetic Nephropathies*/diagnosis
Diabetic Nephropathies*/drug therapy
Diabetic Nephropathies*/epidemiology
Glucagon-Like Peptide-1 Receptor*/agonists
Aged ; Female ; Humans ; Male ; Cohort Studies ; Dipeptidyl-Peptidase IV Inhibitors ; Glucagon-Like Peptide 1 ; Hypoglycemic Agents ; Kidney

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Circulating Dopamine Is Regulated by Dietary Glucose and Controls Glucagon-like 1 Peptide Action in White Adipose Tissue.
Autorzy:: Tavares G; Institute of Physiology and Institute of Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal.; Clinical-Academic Center of Coimbra, 3004-531 Coimbra, Portugal.; NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, 1169-056 Lisbon, Portugal.
Rosendo-Silva D; Institute of Physiology and Institute of Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal.; Clinical-Academic Center of Coimbra, 3004-531 Coimbra, Portugal.
Simões F; Institute of Physiology and Institute of Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.
Eickhoff H; Institute of Physiology and Institute of Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.
Marques D; Institute of Physiology and Institute of Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.
Sacramento JF; NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, 1169-056 Lisbon, Portugal.
Capucho AM; NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, 1169-056 Lisbon, Portugal.
Seiça R; Institute of Physiology and Institute of Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.; Clinical-Academic Center of Coimbra, 3004-531 Coimbra, Portugal.
Conde SV; NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, 1169-056 Lisbon, Portugal.
Matafome P; Institute of Physiology and Institute of Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal.; Clinical-Academic Center of Coimbra, 3004-531 Coimbra, Portugal.; Instituto Politécnico de Coimbra, Coimbra Health School, 3046-854 Coimbra, Portugal.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Jan 27; Vol. 24 (3). Date of Electronic Publication: 2023 Jan 27.
Typ publikacji:: Journal Article
MeSH Terms:: Glucagon*
Glucose*/metabolism
Animals ; Humans ; Rats ; Adipose Tissue, White/metabolism ; Diet, High-Fat ; Dopamine ; Glucagon-Like Peptide 1/metabolism ; Glucagon-Like Peptide-1 Receptor/agonists ; Insulin/metabolism ; Rats, Wistar

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Impact of Glucagon-Like Peptide 1 Receptor Agonists on Biochemical Markers of the Initiation of Atherosclerotic Process.
Autorzy:: Hachuła M; Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyków 18, 40-752 Katowice, Poland.
Kosowski M; Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyków 18, 40-752 Katowice, Poland.
Ryl S; Department of Anaesthesiology and Intensive Care, Municipal Hospital in Zabrze-Biskupice, Zamkowa 4, 41-803 Zabrze, Poland.
Basiak M; Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyków 18, 40-752 Katowice, Poland.
Okopień B; Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyków 18, 40-752 Katowice, Poland.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 03; Vol. 25 (3). Date of Electronic Publication: 2024 Feb 03.
Typ publikacji:: Journal Article
MeSH Terms:: Atherosclerosis*/drug therapy
Atherosclerosis*/metabolism
Diabetes Mellitus, Type 2*/drug therapy
Dyslipidemias*/drug therapy
Glucagon-Like Peptide-1 Receptor*/agonists
Plaque, Atherosclerotic*/drug therapy
Glucagon-Like Peptide-1 Receptor Agonists*/pharmacology
Glucagon-Like Peptide-1 Receptor Agonists*/therapeutic use
Humans ; Biomarkers ; Cytokines/therapeutic use ; Hypoglycemic Agents/therapeutic use ; Interleukin-1beta/therapeutic use ; Tumor Necrosis Factor-alpha/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Glucagon: Physiological and Pharmacological Functions and Pathophysiological Significance in Type 2 Diabetes.
Autorzy:: Kitamura T; Metabolic Signal Research Center, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan.; Pokaż więcej
Źródło:: Endocrinology and metabolism (Seoul, Korea) [Endocrinol Metab (Seoul)] 2024 Feb; Vol. 39 (1), pp. 33-39. Date of Electronic Publication: 2024 Feb 22.
Typ publikacji:: Journal Article
MeSH Terms:: Glucagon*/pharmacology
Glucagon*/physiology
Diabetes Mellitus, Type 2*
Humans ; Insulin ; Glucose ; Liver

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: The impact of macronutrient composition on metabolic regulation: An Islet-Centric view.
Autorzy:: Dos Santos KC; Centre for Analysis and Synthesis, Department of Chemistry, Lund University, Lund, Sweden.; Unit of Molecular Metabolism, Department of Clinical Sciences in Malmö, Lund University, Malmö, Sweden.
Olofsson C; Department of Molecular Medicine and Surgery, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden.
Cunha JPMCM; Unit of Molecular Metabolism, Department of Clinical Sciences in Malmö, Lund University, Malmö, Sweden.
Roberts F; Unit of Molecular Metabolism, Department of Clinical Sciences in Malmö, Lund University, Malmö, Sweden.
Catrina SB; Department of Molecular Medicine and Surgery, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden.; Centrum for Diabetes, Academic Specialist Centrum, Stockholm, Sweden.
Fex M; Unit of Molecular Metabolism, Department of Clinical Sciences in Malmö, Lund University, Malmö, Sweden.
Ekberg NR; Department of Molecular Medicine and Surgery, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden.; Centrum for Diabetes, Academic Specialist Centrum, Stockholm, Sweden.
Spégel P; Centre for Analysis and Synthesis, Department of Chemistry, Lund University, Lund, Sweden.; Pokaż więcej
Źródło:: Acta physiologica (Oxford, England) [Acta Physiol (Oxf)] 2022 Dec; Vol. 236 (4), pp. e13884. Date of Electronic Publication: 2022 Sep 12.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Diabetes Mellitus, Type 2*/metabolism
Glucagon*
Adult ; Aged ; Animals ; Humans ; Mice ; Middle Aged ; Blood Glucose/metabolism ; Glucagon-Like Peptide 1/metabolism ; Glucose/metabolism ; Glycated Hemoglobin ; Insulin/metabolism ; Nutrients ; Obesity ; Palmitates ; Cross-Over Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""glucagon"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji

Starter badań:

Glucagon.